A Case with T-Cell Large Granular Lymphocyte Leukemia Accompanied with Persistent neutropenia without Anemia and Thrombocytopenia

Authors

  • Ji-Hua Jon Department of Hematology, Pyongyang Medical College, KIM IL SUNG University
  • Hye-Song Kim Department of Hematology, Pyongyang Medical College, KIM IL SUNG University
  • Gwang-Il Kim Department of Hematology, Pyongyang Medical College, KIM IL SUNG University

Keywords:

T-cell large granular lymphocyte (T-LGL) leukemia, Lymphocytosis, neutropenia, cyclosporine

Abstract

Abstract

We report a case of T-cell large granular lymphocyte (T-LGL) leukemia accompanied with persistent neutropenia without anemia and thrombocytopenia. A 47-year-old man was diagnosed as T-cell large granular lymphocyte leukemia by clinical feature, a persistent increase in the number of peripheral blood large granular lymphocyte and immune his to chemical analysis. He had the recurrent aphthous stomatitis persisting for more than 1 year. He showed neither lymph node swelling and no accompanied with any autoimmune diseases including rheumatoid arthritis. Lymphocyte count was markedly increased (81%) and neutrophil count decreased (7%) on the peripheral blood smear. Flow cytometric analysis showed that lymphoid cells in the peripheral blood were positive for CD3 (98%), CD5 (96%), CD8 (90%) and negative for CD10 (1%), CD19 (2%), CD20 (3%), CD23 (1%), CD56 (1%) respectively. Because of severe neutropenia, we treated the patient with cyclosporine (300 mg per day for 3 months) with a transient improvement in hematological values, but 3 months after discontinuance of cyclosporine administration, the absolute lymphocyte count and neutrophils count were returned to pretreatment level respectively (lymphocyte 84%, neutrophil 13%). Cyclosporine treatment was immediately restarted with the regulation of dosage according to degree of lymphcytosis and neutropenia, and within 9 months hematologic values normalized. In conclusion, cyclosporine was effective in the treatment of T-cell large granular lymphocyte (T-LGL) leukemia accompanied with persistent neutropenia without anemia and thrombocytopenia and the dosage should be regulated according to the degree of lymphcytosis and neutropenia.

 

Keywords: Cyclosporine, Lymphocytosis, neutropenia, T-cell large granular lymphocyte (T-LGL) leukemia

Cite this Article

Ji-Hua Jon, Hye-Song Kim, So-Mi Jon. A Case with T-Cell Large Granular Lymphocyte Leukemia Accompanied with Persistent neutropenia without Anemia and Thrombocytopenia. Research & Reviews: Journal of Oncology and Hematology. 2020; 9(2): 24–28p.

References

Boeckx N, et al. Clonal proliferation of T- Cell large granular lymphocyte. Pediatr Blood cancer 2004; 42:275

Tariq I Mughal, et al. Understanding Leukemia, Lymphomas and Myelomas. 2006.64~65P

Shinton N.K.,et al. Desk Reference for hematology. 2008.833~834P

Lamy, T, et al. Large granular lymphocyte leukemia. Cancer Control 1998; 5:25.

Morice, WG, et al. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol 2003; 120:1026.

John P.Greer,et al.Wintrobe’s Clinical Hematology.2014;1905.

Sonoko N, et al. CD20- and CD56-Positive T-Cell Large Granular Lymphocyte Leukemia

in a Human T-Cell Leukemia Virus Type 1 Carrier. Int J Hematol 2007; 86:348-351.

McKenna, RW, et al. Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics. Am J Med 1977; 62:588.

Loughran, TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993; 82:1.

Loughran,TP Jr, et al. Clonal proliferation of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1988; 31:31.

Lacy, MQ, et al. A. Pure red cell aplasia: Association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities.Blood 1996; 87:3000.

Kouides, PA, et al. Large granular lymphocyte leukemia presenting with both amegakaryocytic thrombocytopenic purpura and pure red cell aplasia: Clinical course and response to immunosuppressive therapy. Am J Hematol 1995; 49:232.

Gary J., et al. Chronic Leukemias and Lympomas.2003.153~154p

Loughran, TP Jr, et al. Adult onset cyclic neutropenia is associated with increased large granular lymphocytes. Blood 1986; 68:1082.

Pandolfi, F, et al. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer 1990; 65:341.

Dhodapkar, MV, et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: A T-cell clonopathy of undetermined significance? Blood 1994; 84:1620.

Loughran, TP, et al. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994; 84:2164.

Mohan, SR, et al. Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia. Haematologia 2009; 94:1407.

Battiwalla, M, et al. HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders. Br J Haematol 2003; 123:449.

Battiwalla, M, et al. HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders. Br J Haematol 2003; 123:449.

Sood, R, et al. Neutropenia associated With T-cell large granular lymphocyte leukemia: Long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998; 91:3372.

Downloads

Additional Files

Published

2020-09-21

Issue

Vol. 9 No. 2 (2020)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.